Future investigations should lead to a better understanding of whether disrupting Ca2+ entry at KV2–CaV1 nanodomains has beneficial effects on disease progression in NPC disease models, as it does for stroke models66,99. The gene discussed is CAV1; the disease is stroke disorder.